drug · small molecule

inobrodib

Phase 2updated 3mo ago

by CellCentric Ltd🔗 ChEMBL

Phase 2

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.

all catalysts(0)

nothing on the calendar yet

Trials studying inobrodib

phase2Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myelomarecruitingn=100

News(1)

CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
A Series D round led by Venrock will support an ongoing Phase 2 study, and planned Phase 3 trial, of an oral drug the biotech sees as a differentiated option for patients with persistent disease.
biopharma_dive · 3mo ago

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 38m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug · small molecule

save

inobrodib

Phase 2updated 3mo ago

by CellCentric Ltd🔗 ChEMBL

Phase 2

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.

all catalysts(0)

nothing on the calendar yet

Trials studying inobrodib

phase2Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myelomarecruitingn=100

News(1)

CellCentric raises $220M for a ‘transformative’ multiple myeloma medicine
A Series D round led by Venrock will support an ongoing Phase 2 study, and planned Phase 3 trial, of an oral drug the biotech sees as a differentiated option for patients with persistent disease.
biopharma_dive · 3mo ago

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 38m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

inobrodib

all catalysts(0)

Trials studying inobrodib

News(1)

Report a data issue

comments(0)

inobrodib

all catalysts(0)

Trials studying inobrodib

News(1)

Report a data issue

comments(0)